Raja Shankar, VP of machine learning at IQVIA, explains how AI-driven trial simulation and automation are beginning to influence decision-making across every phase of clinical development.
Raja Shankar
Advertisement
Vice President, Machine Learning, Research and Development Solutions, IQVIA
Articles by Raja Shankar
A well-designed approach can benefit clinical trials from protocol design to site support.
Advertisement
Latest Updated Articles
Leveraging AI/Machine Learning as an End-to-End DifferentiatorPublished: December 12th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next
2
SCOPE Summit 2026 Keynote Panel: Is Radical Acceleration in Clinical Research Possible?
3
SCOPE Summit 2026: Elevating Patient Experience in Clinical Operations
4
SCOPE Summit 2026 Keynote Fireside Chat: Aligning Purpose, Innovation, and Operational Excellence in Clinical Development
5